Global PEG-modified Drugs Supply, Demand and Key Producers, 2023-2029
The global PEG-modified Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Polyethylene glycol modified drug refers to a method of drug modification that combines polyethylene glycol molecules with drug molecules to improve the properties, pharmacokinetics and pharmacodynamic properties of drugs. This modification is often used to improve drug solubility, stability, bioavailability, and drug distribution.
This report studies the global PEG-modified Drugs demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for PEG-modified Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of PEG-modified Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global PEG-modified Drugs total market, 2018-2029, (USD Million)
Global PEG-modified Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: PEG-modified Drugs total market, key domestic companies and share, (USD Million)
Global PEG-modified Drugs revenue by player and market share 2018-2023, (USD Million)
Global PEG-modified Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global PEG-modified Drugs total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global PEG-modified Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck Sharp & Dohme, Baxalta Inc., Amgen Inc., Roche, UCB S.A., Enzon, Horizon Pharma Plc, Biogen Inc. and Qilu Pharmaceutical Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PEG-modified Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global PEG-modified Drugs Market, By Region:
1. How big is the global PEG-modified Drugs market?
2. What is the demand of the global PEG-modified Drugs market?
3. What is the year over year growth of the global PEG-modified Drugs market?
4. What is the total value of the global PEG-modified Drugs market?
5. Who are the major players in the global PEG-modified Drugs market?
6. What are the growth factors driving the market demand?
Polyethylene glycol modified drug refers to a method of drug modification that combines polyethylene glycol molecules with drug molecules to improve the properties, pharmacokinetics and pharmacodynamic properties of drugs. This modification is often used to improve drug solubility, stability, bioavailability, and drug distribution.
This report studies the global PEG-modified Drugs demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for PEG-modified Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of PEG-modified Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global PEG-modified Drugs total market, 2018-2029, (USD Million)
Global PEG-modified Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: PEG-modified Drugs total market, key domestic companies and share, (USD Million)
Global PEG-modified Drugs revenue by player and market share 2018-2023, (USD Million)
Global PEG-modified Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global PEG-modified Drugs total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global PEG-modified Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck Sharp & Dohme, Baxalta Inc., Amgen Inc., Roche, UCB S.A., Enzon, Horizon Pharma Plc, Biogen Inc. and Qilu Pharmaceutical Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PEG-modified Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global PEG-modified Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- PEG Amidation
- PEGylation
- PEG Peptidation
- PEG Etherification
- Other Combinations
- Cancer Treatment
- Diabetes Treatment
- Immunomodulatory
- Anti-inflammatory Treatment
- Others
- Merck Sharp & Dohme
- Baxalta Inc.
- Amgen Inc.
- Roche
- UCB S.A.
- Enzon
- Horizon Pharma Plc
- Biogen Inc.
- Qilu Pharmaceutical Co., Ltd.
- CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
- Changchun Genescience Pharmaceutical Co., Ltd.
- Xiamen Amoytop Biotech Co., Ltd.
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Hansoh Pharmaceuticak Group Co.,Ltd.
- SunBio
- Xiamen Sano banger Biotechnology Co., Ltd
1. How big is the global PEG-modified Drugs market?
2. What is the demand of the global PEG-modified Drugs market?
3. What is the year over year growth of the global PEG-modified Drugs market?
4. What is the total value of the global PEG-modified Drugs market?
5. Who are the major players in the global PEG-modified Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 PEG-modified Drugs Introduction
1.2 World PEG-modified Drugs Market Size & Forecast (2018 & 2022 & 2029)
1.3 World PEG-modified Drugs Total Market by Region (by Headquarter Location)
1.3.1 World PEG-modified Drugs Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States PEG-modified Drugs Market Size (2018-2029)
1.3.3 China PEG-modified Drugs Market Size (2018-2029)
1.3.4 Europe PEG-modified Drugs Market Size (2018-2029)
1.3.5 Japan PEG-modified Drugs Market Size (2018-2029)
1.3.6 South Korea PEG-modified Drugs Market Size (2018-2029)
1.3.7 ASEAN PEG-modified Drugs Market Size (2018-2029)
1.3.8 India PEG-modified Drugs Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 PEG-modified Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 PEG-modified Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World PEG-modified Drugs Consumption Value (2018-2029)
2.2 World PEG-modified Drugs Consumption Value by Region
2.2.1 World PEG-modified Drugs Consumption Value by Region (2018-2023)
2.2.2 World PEG-modified Drugs Consumption Value Forecast by Region (2024-2029)
2.3 United States PEG-modified Drugs Consumption Value (2018-2029)
2.4 China PEG-modified Drugs Consumption Value (2018-2029)
2.5 Europe PEG-modified Drugs Consumption Value (2018-2029)
2.6 Japan PEG-modified Drugs Consumption Value (2018-2029)
2.7 South Korea PEG-modified Drugs Consumption Value (2018-2029)
2.8 ASEAN PEG-modified Drugs Consumption Value (2018-2029)
2.9 India PEG-modified Drugs Consumption Value (2018-2029)
3 WORLD PEG-MODIFIED DRUGS COMPANIES COMPETITIVE ANALYSIS
3.1 World PEG-modified Drugs Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global PEG-modified Drugs Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for PEG-modified Drugs in 2022
3.2.3 Global Concentration Ratios (CR8) for PEG-modified Drugs in 2022
3.3 PEG-modified Drugs Company Evaluation Quadrant
3.4 PEG-modified Drugs Market: Overall Company Footprint Analysis
3.4.1 PEG-modified Drugs Market: Region Footprint
3.4.2 PEG-modified Drugs Market: Company Product Type Footprint
3.4.3 PEG-modified Drugs Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: PEG-modified Drugs Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: PEG-modified Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: PEG-modified Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: PEG-modified Drugs Consumption Value Comparison
4.2.1 United States VS China: PEG-modified Drugs Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: PEG-modified Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based PEG-modified Drugs Companies and Market Share, 2018-2023
4.3.1 United States Based PEG-modified Drugs Companies, Headquarters (States, Country)
4.3.2 United States Based Companies PEG-modified Drugs Revenue, (2018-2023)
4.4 China Based Companies PEG-modified Drugs Revenue and Market Share, 2018-2023
4.4.1 China Based PEG-modified Drugs Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies PEG-modified Drugs Revenue, (2018-2023)
4.5 Rest of World Based PEG-modified Drugs Companies and Market Share, 2018-2023
4.5.1 Rest of World Based PEG-modified Drugs Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies PEG-modified Drugs Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World PEG-modified Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 PEG Amidation
5.2.2 PEGylation
5.2.3 PEG Peptidation
5.2.4 PEG Etherification
5.2.5 Other Combinations
5.3 Market Segment by Type
5.3.1 World PEG-modified Drugs Market Size by Type (2018-2023)
5.3.2 World PEG-modified Drugs Market Size by Type (2024-2029)
5.3.3 World PEG-modified Drugs Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World PEG-modified Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cancer Treatment
6.2.2 Diabetes Treatment
6.2.3 Immunomodulatory
6.2.4 Anti-inflammatory Treatment
6.2.5 Anti-inflammatory Treatment
6.3 Market Segment by Application
6.3.1 World PEG-modified Drugs Market Size by Application (2018-2023)
6.3.2 World PEG-modified Drugs Market Size by Application (2024-2029)
6.3.3 World PEG-modified Drugs Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck Sharp & Dohme
7.1.1 Merck Sharp & Dohme Details
7.1.2 Merck Sharp & Dohme Major Business
7.1.3 Merck Sharp & Dohme PEG-modified Drugs Product and Services
7.1.4 Merck Sharp & Dohme PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Merck Sharp & Dohme Recent Developments/Updates
7.1.6 Merck Sharp & Dohme Competitive Strengths & Weaknesses
7.2 Baxalta Inc.
7.2.1 Baxalta Inc. Details
7.2.2 Baxalta Inc. Major Business
7.2.3 Baxalta Inc. PEG-modified Drugs Product and Services
7.2.4 Baxalta Inc. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Baxalta Inc. Recent Developments/Updates
7.2.6 Baxalta Inc. Competitive Strengths & Weaknesses
7.3 Amgen Inc.
7.3.1 Amgen Inc. Details
7.3.2 Amgen Inc. Major Business
7.3.3 Amgen Inc. PEG-modified Drugs Product and Services
7.3.4 Amgen Inc. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Amgen Inc. Recent Developments/Updates
7.3.6 Amgen Inc. Competitive Strengths & Weaknesses
7.4 Roche
7.4.1 Roche Details
7.4.2 Roche Major Business
7.4.3 Roche PEG-modified Drugs Product and Services
7.4.4 Roche PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Roche Recent Developments/Updates
7.4.6 Roche Competitive Strengths & Weaknesses
7.5 UCB S.A.
7.5.1 UCB S.A. Details
7.5.2 UCB S.A. Major Business
7.5.3 UCB S.A. PEG-modified Drugs Product and Services
7.5.4 UCB S.A. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 UCB S.A. Recent Developments/Updates
7.5.6 UCB S.A. Competitive Strengths & Weaknesses
7.6 Enzon
7.6.1 Enzon Details
7.6.2 Enzon Major Business
7.6.3 Enzon PEG-modified Drugs Product and Services
7.6.4 Enzon PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Enzon Recent Developments/Updates
7.6.6 Enzon Competitive Strengths & Weaknesses
7.7 Horizon Pharma Plc
7.7.1 Horizon Pharma Plc Details
7.7.2 Horizon Pharma Plc Major Business
7.7.3 Horizon Pharma Plc PEG-modified Drugs Product and Services
7.7.4 Horizon Pharma Plc PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Horizon Pharma Plc Recent Developments/Updates
7.7.6 Horizon Pharma Plc Competitive Strengths & Weaknesses
7.8 Biogen Inc.
7.8.1 Biogen Inc. Details
7.8.2 Biogen Inc. Major Business
7.8.3 Biogen Inc. PEG-modified Drugs Product and Services
7.8.4 Biogen Inc. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Biogen Inc. Recent Developments/Updates
7.8.6 Biogen Inc. Competitive Strengths & Weaknesses
7.9 Qilu Pharmaceutical Co., Ltd.
7.9.1 Qilu Pharmaceutical Co., Ltd. Details
7.9.2 Qilu Pharmaceutical Co., Ltd. Major Business
7.9.3 Qilu Pharmaceutical Co., Ltd. PEG-modified Drugs Product and Services
7.9.4 Qilu Pharmaceutical Co., Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Qilu Pharmaceutical Co., Ltd. Recent Developments/Updates
7.9.6 Qilu Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.10 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
7.10.1 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Details
7.10.2 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Major Business
7.10.3 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. PEG-modified Drugs Product and Services
7.10.4 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Recent Developments/Updates
7.10.6 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.11 Changchun Genescience Pharmaceutical Co., Ltd.
7.11.1 Changchun Genescience Pharmaceutical Co., Ltd. Details
7.11.2 Changchun Genescience Pharmaceutical Co., Ltd. Major Business
7.11.3 Changchun Genescience Pharmaceutical Co., Ltd. PEG-modified Drugs Product and Services
7.11.4 Changchun Genescience Pharmaceutical Co., Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Changchun Genescience Pharmaceutical Co., Ltd. Recent Developments/Updates
7.11.6 Changchun Genescience Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.12 Xiamen Amoytop Biotech Co., Ltd.
7.12.1 Xiamen Amoytop Biotech Co., Ltd. Details
7.12.2 Xiamen Amoytop Biotech Co., Ltd. Major Business
7.12.3 Xiamen Amoytop Biotech Co., Ltd. PEG-modified Drugs Product and Services
7.12.4 Xiamen Amoytop Biotech Co., Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Xiamen Amoytop Biotech Co., Ltd. Recent Developments/Updates
7.12.6 Xiamen Amoytop Biotech Co., Ltd. Competitive Strengths & Weaknesses
7.13 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
7.13.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Details
7.13.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
7.13.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. PEG-modified Drugs Product and Services
7.13.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
7.13.6 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
7.14 Hansoh Pharmaceuticak Group Co.,Ltd.
7.14.1 Hansoh Pharmaceuticak Group Co.,Ltd. Details
7.14.2 Hansoh Pharmaceuticak Group Co.,Ltd. Major Business
7.14.3 Hansoh Pharmaceuticak Group Co.,Ltd. PEG-modified Drugs Product and Services
7.14.4 Hansoh Pharmaceuticak Group Co.,Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Hansoh Pharmaceuticak Group Co.,Ltd. Recent Developments/Updates
7.14.6 Hansoh Pharmaceuticak Group Co.,Ltd. Competitive Strengths & Weaknesses
7.15 SunBio
7.15.1 SunBio Details
7.15.2 SunBio Major Business
7.15.3 SunBio PEG-modified Drugs Product and Services
7.15.4 SunBio PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 SunBio Recent Developments/Updates
7.15.6 SunBio Competitive Strengths & Weaknesses
7.16 Xiamen Sano banger Biotechnology Co., Ltd
7.16.1 Xiamen Sano banger Biotechnology Co., Ltd Details
7.16.2 Xiamen Sano banger Biotechnology Co., Ltd Major Business
7.16.3 Xiamen Sano banger Biotechnology Co., Ltd PEG-modified Drugs Product and Services
7.16.4 Xiamen Sano banger Biotechnology Co., Ltd PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Xiamen Sano banger Biotechnology Co., Ltd Recent Developments/Updates
7.16.6 Xiamen Sano banger Biotechnology Co., Ltd Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 PEG-modified Drugs Industry Chain
8.2 PEG-modified Drugs Upstream Analysis
8.3 PEG-modified Drugs Midstream Analysis
8.4 PEG-modified Drugs Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 PEG-modified Drugs Introduction
1.2 World PEG-modified Drugs Market Size & Forecast (2018 & 2022 & 2029)
1.3 World PEG-modified Drugs Total Market by Region (by Headquarter Location)
1.3.1 World PEG-modified Drugs Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States PEG-modified Drugs Market Size (2018-2029)
1.3.3 China PEG-modified Drugs Market Size (2018-2029)
1.3.4 Europe PEG-modified Drugs Market Size (2018-2029)
1.3.5 Japan PEG-modified Drugs Market Size (2018-2029)
1.3.6 South Korea PEG-modified Drugs Market Size (2018-2029)
1.3.7 ASEAN PEG-modified Drugs Market Size (2018-2029)
1.3.8 India PEG-modified Drugs Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 PEG-modified Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 PEG-modified Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World PEG-modified Drugs Consumption Value (2018-2029)
2.2 World PEG-modified Drugs Consumption Value by Region
2.2.1 World PEG-modified Drugs Consumption Value by Region (2018-2023)
2.2.2 World PEG-modified Drugs Consumption Value Forecast by Region (2024-2029)
2.3 United States PEG-modified Drugs Consumption Value (2018-2029)
2.4 China PEG-modified Drugs Consumption Value (2018-2029)
2.5 Europe PEG-modified Drugs Consumption Value (2018-2029)
2.6 Japan PEG-modified Drugs Consumption Value (2018-2029)
2.7 South Korea PEG-modified Drugs Consumption Value (2018-2029)
2.8 ASEAN PEG-modified Drugs Consumption Value (2018-2029)
2.9 India PEG-modified Drugs Consumption Value (2018-2029)
3 WORLD PEG-MODIFIED DRUGS COMPANIES COMPETITIVE ANALYSIS
3.1 World PEG-modified Drugs Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global PEG-modified Drugs Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for PEG-modified Drugs in 2022
3.2.3 Global Concentration Ratios (CR8) for PEG-modified Drugs in 2022
3.3 PEG-modified Drugs Company Evaluation Quadrant
3.4 PEG-modified Drugs Market: Overall Company Footprint Analysis
3.4.1 PEG-modified Drugs Market: Region Footprint
3.4.2 PEG-modified Drugs Market: Company Product Type Footprint
3.4.3 PEG-modified Drugs Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: PEG-modified Drugs Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: PEG-modified Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: PEG-modified Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: PEG-modified Drugs Consumption Value Comparison
4.2.1 United States VS China: PEG-modified Drugs Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: PEG-modified Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based PEG-modified Drugs Companies and Market Share, 2018-2023
4.3.1 United States Based PEG-modified Drugs Companies, Headquarters (States, Country)
4.3.2 United States Based Companies PEG-modified Drugs Revenue, (2018-2023)
4.4 China Based Companies PEG-modified Drugs Revenue and Market Share, 2018-2023
4.4.1 China Based PEG-modified Drugs Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies PEG-modified Drugs Revenue, (2018-2023)
4.5 Rest of World Based PEG-modified Drugs Companies and Market Share, 2018-2023
4.5.1 Rest of World Based PEG-modified Drugs Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies PEG-modified Drugs Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World PEG-modified Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 PEG Amidation
5.2.2 PEGylation
5.2.3 PEG Peptidation
5.2.4 PEG Etherification
5.2.5 Other Combinations
5.3 Market Segment by Type
5.3.1 World PEG-modified Drugs Market Size by Type (2018-2023)
5.3.2 World PEG-modified Drugs Market Size by Type (2024-2029)
5.3.3 World PEG-modified Drugs Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World PEG-modified Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cancer Treatment
6.2.2 Diabetes Treatment
6.2.3 Immunomodulatory
6.2.4 Anti-inflammatory Treatment
6.2.5 Anti-inflammatory Treatment
6.3 Market Segment by Application
6.3.1 World PEG-modified Drugs Market Size by Application (2018-2023)
6.3.2 World PEG-modified Drugs Market Size by Application (2024-2029)
6.3.3 World PEG-modified Drugs Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck Sharp & Dohme
7.1.1 Merck Sharp & Dohme Details
7.1.2 Merck Sharp & Dohme Major Business
7.1.3 Merck Sharp & Dohme PEG-modified Drugs Product and Services
7.1.4 Merck Sharp & Dohme PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Merck Sharp & Dohme Recent Developments/Updates
7.1.6 Merck Sharp & Dohme Competitive Strengths & Weaknesses
7.2 Baxalta Inc.
7.2.1 Baxalta Inc. Details
7.2.2 Baxalta Inc. Major Business
7.2.3 Baxalta Inc. PEG-modified Drugs Product and Services
7.2.4 Baxalta Inc. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Baxalta Inc. Recent Developments/Updates
7.2.6 Baxalta Inc. Competitive Strengths & Weaknesses
7.3 Amgen Inc.
7.3.1 Amgen Inc. Details
7.3.2 Amgen Inc. Major Business
7.3.3 Amgen Inc. PEG-modified Drugs Product and Services
7.3.4 Amgen Inc. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Amgen Inc. Recent Developments/Updates
7.3.6 Amgen Inc. Competitive Strengths & Weaknesses
7.4 Roche
7.4.1 Roche Details
7.4.2 Roche Major Business
7.4.3 Roche PEG-modified Drugs Product and Services
7.4.4 Roche PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Roche Recent Developments/Updates
7.4.6 Roche Competitive Strengths & Weaknesses
7.5 UCB S.A.
7.5.1 UCB S.A. Details
7.5.2 UCB S.A. Major Business
7.5.3 UCB S.A. PEG-modified Drugs Product and Services
7.5.4 UCB S.A. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 UCB S.A. Recent Developments/Updates
7.5.6 UCB S.A. Competitive Strengths & Weaknesses
7.6 Enzon
7.6.1 Enzon Details
7.6.2 Enzon Major Business
7.6.3 Enzon PEG-modified Drugs Product and Services
7.6.4 Enzon PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Enzon Recent Developments/Updates
7.6.6 Enzon Competitive Strengths & Weaknesses
7.7 Horizon Pharma Plc
7.7.1 Horizon Pharma Plc Details
7.7.2 Horizon Pharma Plc Major Business
7.7.3 Horizon Pharma Plc PEG-modified Drugs Product and Services
7.7.4 Horizon Pharma Plc PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Horizon Pharma Plc Recent Developments/Updates
7.7.6 Horizon Pharma Plc Competitive Strengths & Weaknesses
7.8 Biogen Inc.
7.8.1 Biogen Inc. Details
7.8.2 Biogen Inc. Major Business
7.8.3 Biogen Inc. PEG-modified Drugs Product and Services
7.8.4 Biogen Inc. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Biogen Inc. Recent Developments/Updates
7.8.6 Biogen Inc. Competitive Strengths & Weaknesses
7.9 Qilu Pharmaceutical Co., Ltd.
7.9.1 Qilu Pharmaceutical Co., Ltd. Details
7.9.2 Qilu Pharmaceutical Co., Ltd. Major Business
7.9.3 Qilu Pharmaceutical Co., Ltd. PEG-modified Drugs Product and Services
7.9.4 Qilu Pharmaceutical Co., Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Qilu Pharmaceutical Co., Ltd. Recent Developments/Updates
7.9.6 Qilu Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.10 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
7.10.1 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Details
7.10.2 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Major Business
7.10.3 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. PEG-modified Drugs Product and Services
7.10.4 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Recent Developments/Updates
7.10.6 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.11 Changchun Genescience Pharmaceutical Co., Ltd.
7.11.1 Changchun Genescience Pharmaceutical Co., Ltd. Details
7.11.2 Changchun Genescience Pharmaceutical Co., Ltd. Major Business
7.11.3 Changchun Genescience Pharmaceutical Co., Ltd. PEG-modified Drugs Product and Services
7.11.4 Changchun Genescience Pharmaceutical Co., Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Changchun Genescience Pharmaceutical Co., Ltd. Recent Developments/Updates
7.11.6 Changchun Genescience Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.12 Xiamen Amoytop Biotech Co., Ltd.
7.12.1 Xiamen Amoytop Biotech Co., Ltd. Details
7.12.2 Xiamen Amoytop Biotech Co., Ltd. Major Business
7.12.3 Xiamen Amoytop Biotech Co., Ltd. PEG-modified Drugs Product and Services
7.12.4 Xiamen Amoytop Biotech Co., Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Xiamen Amoytop Biotech Co., Ltd. Recent Developments/Updates
7.12.6 Xiamen Amoytop Biotech Co., Ltd. Competitive Strengths & Weaknesses
7.13 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
7.13.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Details
7.13.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
7.13.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. PEG-modified Drugs Product and Services
7.13.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
7.13.6 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
7.14 Hansoh Pharmaceuticak Group Co.,Ltd.
7.14.1 Hansoh Pharmaceuticak Group Co.,Ltd. Details
7.14.2 Hansoh Pharmaceuticak Group Co.,Ltd. Major Business
7.14.3 Hansoh Pharmaceuticak Group Co.,Ltd. PEG-modified Drugs Product and Services
7.14.4 Hansoh Pharmaceuticak Group Co.,Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Hansoh Pharmaceuticak Group Co.,Ltd. Recent Developments/Updates
7.14.6 Hansoh Pharmaceuticak Group Co.,Ltd. Competitive Strengths & Weaknesses
7.15 SunBio
7.15.1 SunBio Details
7.15.2 SunBio Major Business
7.15.3 SunBio PEG-modified Drugs Product and Services
7.15.4 SunBio PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 SunBio Recent Developments/Updates
7.15.6 SunBio Competitive Strengths & Weaknesses
7.16 Xiamen Sano banger Biotechnology Co., Ltd
7.16.1 Xiamen Sano banger Biotechnology Co., Ltd Details
7.16.2 Xiamen Sano banger Biotechnology Co., Ltd Major Business
7.16.3 Xiamen Sano banger Biotechnology Co., Ltd PEG-modified Drugs Product and Services
7.16.4 Xiamen Sano banger Biotechnology Co., Ltd PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Xiamen Sano banger Biotechnology Co., Ltd Recent Developments/Updates
7.16.6 Xiamen Sano banger Biotechnology Co., Ltd Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 PEG-modified Drugs Industry Chain
8.2 PEG-modified Drugs Upstream Analysis
8.3 PEG-modified Drugs Midstream Analysis
8.4 PEG-modified Drugs Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World PEG-modified Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World PEG-modified Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World PEG-modified Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World PEG-modified Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World PEG-modified Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World PEG-modified Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World PEG-modified Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World PEG-modified Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World PEG-modified Drugs Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key PEG-modified Drugs Players in 2022
Table 12. World PEG-modified Drugs Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global PEG-modified Drugs Company Evaluation Quadrant
Table 14. Head Office of Key PEG-modified Drugs Player
Table 15. PEG-modified Drugs Market: Company Product Type Footprint
Table 16. PEG-modified Drugs Market: Company Product Application Footprint
Table 17. PEG-modified Drugs Mergers & Acquisitions Activity
Table 18. United States VS China PEG-modified Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China PEG-modified Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based PEG-modified Drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies PEG-modified Drugs Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies PEG-modified Drugs Revenue Market Share (2018-2023)
Table 23. China Based PEG-modified Drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies PEG-modified Drugs Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies PEG-modified Drugs Revenue Market Share (2018-2023)
Table 26. Rest of World Based PEG-modified Drugs Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies PEG-modified Drugs Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies PEG-modified Drugs Revenue Market Share (2018-2023)
Table 29. World PEG-modified Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World PEG-modified Drugs Market Size by Type (2018-2023) & (USD Million)
Table 31. World PEG-modified Drugs Market Size by Type (2024-2029) & (USD Million)
Table 32. World PEG-modified Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World PEG-modified Drugs Market Size by Application (2018-2023) & (USD Million)
Table 34. World PEG-modified Drugs Market Size by Application (2024-2029) & (USD Million)
Table 35. Merck Sharp & Dohme Basic Information, Area Served and Competitors
Table 36. Merck Sharp & Dohme Major Business
Table 37. Merck Sharp & Dohme PEG-modified Drugs Product and Services
Table 38. Merck Sharp & Dohme PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Merck Sharp & Dohme Recent Developments/Updates
Table 40. Merck Sharp & Dohme Competitive Strengths & Weaknesses
Table 41. Baxalta Inc. Basic Information, Area Served and Competitors
Table 42. Baxalta Inc. Major Business
Table 43. Baxalta Inc. PEG-modified Drugs Product and Services
Table 44. Baxalta Inc. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Baxalta Inc. Recent Developments/Updates
Table 46. Baxalta Inc. Competitive Strengths & Weaknesses
Table 47. Amgen Inc. Basic Information, Area Served and Competitors
Table 48. Amgen Inc. Major Business
Table 49. Amgen Inc. PEG-modified Drugs Product and Services
Table 50. Amgen Inc. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Amgen Inc. Recent Developments/Updates
Table 52. Amgen Inc. Competitive Strengths & Weaknesses
Table 53. Roche Basic Information, Area Served and Competitors
Table 54. Roche Major Business
Table 55. Roche PEG-modified Drugs Product and Services
Table 56. Roche PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Roche Recent Developments/Updates
Table 58. Roche Competitive Strengths & Weaknesses
Table 59. UCB S.A. Basic Information, Area Served and Competitors
Table 60. UCB S.A. Major Business
Table 61. UCB S.A. PEG-modified Drugs Product and Services
Table 62. UCB S.A. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. UCB S.A. Recent Developments/Updates
Table 64. UCB S.A. Competitive Strengths & Weaknesses
Table 65. Enzon Basic Information, Area Served and Competitors
Table 66. Enzon Major Business
Table 67. Enzon PEG-modified Drugs Product and Services
Table 68. Enzon PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Enzon Recent Developments/Updates
Table 70. Enzon Competitive Strengths & Weaknesses
Table 71. Horizon Pharma Plc Basic Information, Area Served and Competitors
Table 72. Horizon Pharma Plc Major Business
Table 73. Horizon Pharma Plc PEG-modified Drugs Product and Services
Table 74. Horizon Pharma Plc PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Horizon Pharma Plc Recent Developments/Updates
Table 76. Horizon Pharma Plc Competitive Strengths & Weaknesses
Table 77. Biogen Inc. Basic Information, Area Served and Competitors
Table 78. Biogen Inc. Major Business
Table 79. Biogen Inc. PEG-modified Drugs Product and Services
Table 80. Biogen Inc. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Biogen Inc. Recent Developments/Updates
Table 82. Biogen Inc. Competitive Strengths & Weaknesses
Table 83. Qilu Pharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
Table 84. Qilu Pharmaceutical Co., Ltd. Major Business
Table 85. Qilu Pharmaceutical Co., Ltd. PEG-modified Drugs Product and Services
Table 86. Qilu Pharmaceutical Co., Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Qilu Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 88. Qilu Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 89. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
Table 90. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Major Business
Table 91. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. PEG-modified Drugs Product and Services
Table 92. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 94. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 95. Changchun Genescience Pharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
Table 96. Changchun Genescience Pharmaceutical Co., Ltd. Major Business
Table 97. Changchun Genescience Pharmaceutical Co., Ltd. PEG-modified Drugs Product and Services
Table 98. Changchun Genescience Pharmaceutical Co., Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Changchun Genescience Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 100. Changchun Genescience Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 101. Xiamen Amoytop Biotech Co., Ltd. Basic Information, Area Served and Competitors
Table 102. Xiamen Amoytop Biotech Co., Ltd. Major Business
Table 103. Xiamen Amoytop Biotech Co., Ltd. PEG-modified Drugs Product and Services
Table 104. Xiamen Amoytop Biotech Co., Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Xiamen Amoytop Biotech Co., Ltd. Recent Developments/Updates
Table 106. Xiamen Amoytop Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 107. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Basic Information, Area Served and Competitors
Table 108. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
Table 109. Jiangsu Hengrui Pharmaceuticals Co., Ltd. PEG-modified Drugs Product and Services
Table 110. Jiangsu Hengrui Pharmaceuticals Co., Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 112. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
Table 113. Hansoh Pharmaceuticak Group Co.,Ltd. Basic Information, Area Served and Competitors
Table 114. Hansoh Pharmaceuticak Group Co.,Ltd. Major Business
Table 115. Hansoh Pharmaceuticak Group Co.,Ltd. PEG-modified Drugs Product and Services
Table 116. Hansoh Pharmaceuticak Group Co.,Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Hansoh Pharmaceuticak Group Co.,Ltd. Recent Developments/Updates
Table 118. Hansoh Pharmaceuticak Group Co.,Ltd. Competitive Strengths & Weaknesses
Table 119. SunBio Basic Information, Area Served and Competitors
Table 120. SunBio Major Business
Table 121. SunBio PEG-modified Drugs Product and Services
Table 122. SunBio PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. SunBio Recent Developments/Updates
Table 124. Xiamen Sano banger Biotechnology Co., Ltd Basic Information, Area Served and Competitors
Table 125. Xiamen Sano banger Biotechnology Co., Ltd Major Business
Table 126. Xiamen Sano banger Biotechnology Co., Ltd PEG-modified Drugs Product and Services
Table 127. Xiamen Sano banger Biotechnology Co., Ltd PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 128. Global Key Players of PEG-modified Drugs Upstream (Raw Materials)
Table 129. PEG-modified Drugs Typical Customers
Table 1. World PEG-modified Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World PEG-modified Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World PEG-modified Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World PEG-modified Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World PEG-modified Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World PEG-modified Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World PEG-modified Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World PEG-modified Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World PEG-modified Drugs Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key PEG-modified Drugs Players in 2022
Table 12. World PEG-modified Drugs Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global PEG-modified Drugs Company Evaluation Quadrant
Table 14. Head Office of Key PEG-modified Drugs Player
Table 15. PEG-modified Drugs Market: Company Product Type Footprint
Table 16. PEG-modified Drugs Market: Company Product Application Footprint
Table 17. PEG-modified Drugs Mergers & Acquisitions Activity
Table 18. United States VS China PEG-modified Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China PEG-modified Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based PEG-modified Drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies PEG-modified Drugs Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies PEG-modified Drugs Revenue Market Share (2018-2023)
Table 23. China Based PEG-modified Drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies PEG-modified Drugs Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies PEG-modified Drugs Revenue Market Share (2018-2023)
Table 26. Rest of World Based PEG-modified Drugs Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies PEG-modified Drugs Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies PEG-modified Drugs Revenue Market Share (2018-2023)
Table 29. World PEG-modified Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World PEG-modified Drugs Market Size by Type (2018-2023) & (USD Million)
Table 31. World PEG-modified Drugs Market Size by Type (2024-2029) & (USD Million)
Table 32. World PEG-modified Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World PEG-modified Drugs Market Size by Application (2018-2023) & (USD Million)
Table 34. World PEG-modified Drugs Market Size by Application (2024-2029) & (USD Million)
Table 35. Merck Sharp & Dohme Basic Information, Area Served and Competitors
Table 36. Merck Sharp & Dohme Major Business
Table 37. Merck Sharp & Dohme PEG-modified Drugs Product and Services
Table 38. Merck Sharp & Dohme PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Merck Sharp & Dohme Recent Developments/Updates
Table 40. Merck Sharp & Dohme Competitive Strengths & Weaknesses
Table 41. Baxalta Inc. Basic Information, Area Served and Competitors
Table 42. Baxalta Inc. Major Business
Table 43. Baxalta Inc. PEG-modified Drugs Product and Services
Table 44. Baxalta Inc. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Baxalta Inc. Recent Developments/Updates
Table 46. Baxalta Inc. Competitive Strengths & Weaknesses
Table 47. Amgen Inc. Basic Information, Area Served and Competitors
Table 48. Amgen Inc. Major Business
Table 49. Amgen Inc. PEG-modified Drugs Product and Services
Table 50. Amgen Inc. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Amgen Inc. Recent Developments/Updates
Table 52. Amgen Inc. Competitive Strengths & Weaknesses
Table 53. Roche Basic Information, Area Served and Competitors
Table 54. Roche Major Business
Table 55. Roche PEG-modified Drugs Product and Services
Table 56. Roche PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Roche Recent Developments/Updates
Table 58. Roche Competitive Strengths & Weaknesses
Table 59. UCB S.A. Basic Information, Area Served and Competitors
Table 60. UCB S.A. Major Business
Table 61. UCB S.A. PEG-modified Drugs Product and Services
Table 62. UCB S.A. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. UCB S.A. Recent Developments/Updates
Table 64. UCB S.A. Competitive Strengths & Weaknesses
Table 65. Enzon Basic Information, Area Served and Competitors
Table 66. Enzon Major Business
Table 67. Enzon PEG-modified Drugs Product and Services
Table 68. Enzon PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Enzon Recent Developments/Updates
Table 70. Enzon Competitive Strengths & Weaknesses
Table 71. Horizon Pharma Plc Basic Information, Area Served and Competitors
Table 72. Horizon Pharma Plc Major Business
Table 73. Horizon Pharma Plc PEG-modified Drugs Product and Services
Table 74. Horizon Pharma Plc PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Horizon Pharma Plc Recent Developments/Updates
Table 76. Horizon Pharma Plc Competitive Strengths & Weaknesses
Table 77. Biogen Inc. Basic Information, Area Served and Competitors
Table 78. Biogen Inc. Major Business
Table 79. Biogen Inc. PEG-modified Drugs Product and Services
Table 80. Biogen Inc. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Biogen Inc. Recent Developments/Updates
Table 82. Biogen Inc. Competitive Strengths & Weaknesses
Table 83. Qilu Pharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
Table 84. Qilu Pharmaceutical Co., Ltd. Major Business
Table 85. Qilu Pharmaceutical Co., Ltd. PEG-modified Drugs Product and Services
Table 86. Qilu Pharmaceutical Co., Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Qilu Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 88. Qilu Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 89. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
Table 90. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Major Business
Table 91. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. PEG-modified Drugs Product and Services
Table 92. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 94. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 95. Changchun Genescience Pharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
Table 96. Changchun Genescience Pharmaceutical Co., Ltd. Major Business
Table 97. Changchun Genescience Pharmaceutical Co., Ltd. PEG-modified Drugs Product and Services
Table 98. Changchun Genescience Pharmaceutical Co., Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Changchun Genescience Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 100. Changchun Genescience Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 101. Xiamen Amoytop Biotech Co., Ltd. Basic Information, Area Served and Competitors
Table 102. Xiamen Amoytop Biotech Co., Ltd. Major Business
Table 103. Xiamen Amoytop Biotech Co., Ltd. PEG-modified Drugs Product and Services
Table 104. Xiamen Amoytop Biotech Co., Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Xiamen Amoytop Biotech Co., Ltd. Recent Developments/Updates
Table 106. Xiamen Amoytop Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 107. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Basic Information, Area Served and Competitors
Table 108. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
Table 109. Jiangsu Hengrui Pharmaceuticals Co., Ltd. PEG-modified Drugs Product and Services
Table 110. Jiangsu Hengrui Pharmaceuticals Co., Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 112. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
Table 113. Hansoh Pharmaceuticak Group Co.,Ltd. Basic Information, Area Served and Competitors
Table 114. Hansoh Pharmaceuticak Group Co.,Ltd. Major Business
Table 115. Hansoh Pharmaceuticak Group Co.,Ltd. PEG-modified Drugs Product and Services
Table 116. Hansoh Pharmaceuticak Group Co.,Ltd. PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Hansoh Pharmaceuticak Group Co.,Ltd. Recent Developments/Updates
Table 118. Hansoh Pharmaceuticak Group Co.,Ltd. Competitive Strengths & Weaknesses
Table 119. SunBio Basic Information, Area Served and Competitors
Table 120. SunBio Major Business
Table 121. SunBio PEG-modified Drugs Product and Services
Table 122. SunBio PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. SunBio Recent Developments/Updates
Table 124. Xiamen Sano banger Biotechnology Co., Ltd Basic Information, Area Served and Competitors
Table 125. Xiamen Sano banger Biotechnology Co., Ltd Major Business
Table 126. Xiamen Sano banger Biotechnology Co., Ltd PEG-modified Drugs Product and Services
Table 127. Xiamen Sano banger Biotechnology Co., Ltd PEG-modified Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 128. Global Key Players of PEG-modified Drugs Upstream (Raw Materials)
Table 129. PEG-modified Drugs Typical Customers
LIST OF FIGURES
Figure 1. PEG-modified Drugs Picture
Figure 2. World PEG-modified Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World PEG-modified Drugs Total Market Size (2018-2029) & (USD Million)
Figure 4. World PEG-modified Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World PEG-modified Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company PEG-modified Drugs Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company PEG-modified Drugs Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company PEG-modified Drugs Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company PEG-modified Drugs Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company PEG-modified Drugs Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company PEG-modified Drugs Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company PEG-modified Drugs Revenue (2018-2029) & (USD Million)
Figure 13. PEG-modified Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World PEG-modified Drugs Consumption Value (2018-2029) & (USD Million)
Figure 16. World PEG-modified Drugs Consumption Value Market Share by Region (2018-2029)
Figure 17. United States PEG-modified Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. China PEG-modified Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe PEG-modified Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan PEG-modified Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea PEG-modified Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN PEG-modified Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. India PEG-modified Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of PEG-modified Drugs by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for PEG-modified Drugs Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for PEG-modified Drugs Markets in 2022
Figure 27. United States VS China: PEG-modified Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: PEG-modified Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World PEG-modified Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World PEG-modified Drugs Market Size Market Share by Type in 2022
Figure 31. PEG Amidation
Figure 32. PEGylation
Figure 33. PEG Peptidation
Figure 34. PEG Etherification
Figure 35. Other Combinations
Figure 36. World PEG-modified Drugs Market Size Market Share by Type (2018-2029)
Figure 37. World PEG-modified Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World PEG-modified Drugs Market Size Market Share by Application in 2022
Figure 39. Cancer Treatment
Figure 40. Diabetes Treatment
Figure 41. Immunomodulatory
Figure 42. Anti-inflammatory Treatment
Figure 43. Others
Figure 44. PEG-modified Drugs Industrial Chain
Figure 45. Methodology
Figure 46. Research Process and Data Source
Figure 1. PEG-modified Drugs Picture
Figure 2. World PEG-modified Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World PEG-modified Drugs Total Market Size (2018-2029) & (USD Million)
Figure 4. World PEG-modified Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World PEG-modified Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company PEG-modified Drugs Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company PEG-modified Drugs Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company PEG-modified Drugs Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company PEG-modified Drugs Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company PEG-modified Drugs Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company PEG-modified Drugs Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company PEG-modified Drugs Revenue (2018-2029) & (USD Million)
Figure 13. PEG-modified Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World PEG-modified Drugs Consumption Value (2018-2029) & (USD Million)
Figure 16. World PEG-modified Drugs Consumption Value Market Share by Region (2018-2029)
Figure 17. United States PEG-modified Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. China PEG-modified Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe PEG-modified Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan PEG-modified Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea PEG-modified Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN PEG-modified Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. India PEG-modified Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of PEG-modified Drugs by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for PEG-modified Drugs Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for PEG-modified Drugs Markets in 2022
Figure 27. United States VS China: PEG-modified Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: PEG-modified Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World PEG-modified Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World PEG-modified Drugs Market Size Market Share by Type in 2022
Figure 31. PEG Amidation
Figure 32. PEGylation
Figure 33. PEG Peptidation
Figure 34. PEG Etherification
Figure 35. Other Combinations
Figure 36. World PEG-modified Drugs Market Size Market Share by Type (2018-2029)
Figure 37. World PEG-modified Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World PEG-modified Drugs Market Size Market Share by Application in 2022
Figure 39. Cancer Treatment
Figure 40. Diabetes Treatment
Figure 41. Immunomodulatory
Figure 42. Anti-inflammatory Treatment
Figure 43. Others
Figure 44. PEG-modified Drugs Industrial Chain
Figure 45. Methodology
Figure 46. Research Process and Data Source
